home / stock / iqaif / iqaif quote
Last: | $0.02 |
---|---|
Change Percent: | 0.0% |
Open: | $0.02 |
Close: | $0.02 |
High: | $0.02 |
Low: | $0.02 |
Volume: | 19,952 |
Last Trade Date Time: | 05/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 19,952 | 05-22-2024 |
$0.015 | $0.015 | $0.015 | $0.015 | $0.015 | 19,952 | 05-21-2024 |
$0.017 | $0.017 | $0.017 | $0.017 | $0.017 | 100,000 | 04-10-2024 |
$0.016 | $0.017 | $0.016 | $0.017 | $0.016 | 210,000 | 04-09-2024 |
$0.0194 | $0.0194 | $0.0194 | $0.0194 | $0.0194 | 9,523 | 02-29-2024 |
$0.0192 | $0.021 | $0.0192 | $0.021 | $0.0192 | 19,523 | 02-22-2024 |
$0.029 | $0.029 | $0.029 | $0.029 | $0.029 | 200,000 | 02-14-2024 |
$0.031 | $0.031 | $0.031 | $0.031 | $0.031 | 100,000 | 02-13-2024 |
$0.037 | $0 | $0.037 | $0 | $0 | 48 | 01-26-2024 |
$0.037 | $0.042 | $0.037 | $0.042 | $0.037 | 185,000 | 01-18-2024 |
$0.046 | $0 | $0.046 | $0 | $0 | 48 | 01-16-2024 |
$0.046 | $0.05 | $0.046 | $0.05 | $0.046 | 1,055,000 | 01-10-2024 |
$0.0517 | $0.052 | $0.0517 | $0.055 | $0.05 | 760,000 | 01-09-2024 |
$0.046 | $0.046 | $0.046 | $0.046 | $0.046 | 25,000 | 10-23-2023 |
$0.021 | $0 | $0.021 | $0 | $0 | 202 | 08-02-2023 |
$0.021 | $0 | $0.021 | $0 | $0 | 48 | 07-31-2023 |
$0.021 | $0 | $0.021 | $0 | $0 | 20 | 07-27-2023 |
$0.021 | $0 | $0.021 | $0 | $0 | 28 | 07-26-2023 |
$0.021 | $0.021 | $0.021 | $0.021 | $0.021 | 200 | 11-21-2022 |
$0.024 | $0.024 | $0.024 | $0.024 | $0.024 | 200 | 11-15-2022 |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Limited sponsored phase one clinical trial that is being conducted at the Medical College of Wisconsin, joined Proactive's Stephen Gunnion with a positive update from its treatment for recurring glioblasto...
--News Direct-- Dr Jennifer Connelly, the Principal Investigator (PI) of the IQ-AI Limited sponsored Phase I Clinical Trial that is being conducted at the Medical College of Wisconsin, joins Proactive's Natalie Stoberman to discuss the latest updates from its treatment for recurring gliob...
MILWAUKEE, WI / ACCESSWIRE / July 13, 2023 / Imaging Biometrics, LLC (IB) , a wholly-owned subsidiary of IQ-AI Ltd (LSE:IQAI)(OTCQB:IQAIF) , today announced the U.S. Food and Drug Administration (US FDA) has granted Orphan Drug Designation (ODD) for gallium maltolate (GaM) for the treatment of p...